Gachon University Gil Hospital introduces and operates an advanced treatment system that treats prostate hyperplasia using high-temperature water vapor. Gachon University Gil Hospital (Hospital ...

Teleflex’s TFX Interventional Urology portfolio is well positioned for sustained growth, led by UroLift’s expanding global ...

While age has always been the strongest risk factor for benign prostatic hyperplasia (BPH), ethnicity and lifestyle factors also play a big role in its onset. W ...

ProVerum and Zenflow both this week announced FDA approvals for their technologies that treat benign prostatic hyperplasia ...

The U.S. Food and Drug Administration (FDA) have granted approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj), ...

The prostatic urethral stent for relief of lower urinary tract symptoms from benign prostatic hyperplasia (BPH) was tested in the ProVide trial.

U.S. Food and Drug Administration (FDA) approval of the Zenflow Spring(R) Implant and Delivery System for the treatment of symptoms associated with benign prostatic hyperplasia (BPH), also known as ...

In a recent interview with CURE, Dr. Kai Tsao broke down current treatment advancements for patients with prostate cancer.

Before having cataract surgery, any person who has ever taken an alpha blocker should tell their eye surgeon. Tamsulosin is ...

An FDA panel of experts has called for a loosening of regulations and expanding access to testosterone replacement therapy.

The drugs have soared in popularity, with some men taking them for unapproved uses like anti-aging or increasing muscle mass.

The U.S. FDA recently cleared two new medical devices to treat benign prostatic hyperplasia, offering men with enlarged prostates additional treatment options which are minimally invasive. The ...